Literature DB >> 7676639

An essential role for type 1 interferon-gamma in terminating persistent viral infection.

A Tishon1, H Lewicki, G Rall, M Von Herrath, M B Oldstone.   

Abstract

The mechanism(s) by which infectious material is cleared by the host is an area of intensive study. This is especially so with the realization that persistent viral infection is a cause of chronic disease in humans and presents a major health problem. We have used the murine model of infection with lymphocytic choriomeningitis virus to evaluate immune clearance. Mice with a targeted disruption of the IFN-gamma gene mount effective cytotoxic T lymphocyte (CTL) responses after an acute viral challenge and clear virus. CD4+ T cells are not required but CD8+ T cells are mandatory. In contrast, CTL from mice with targeted disruption of the IFN-gamma gene are unable to clear virus from persistently infected mice. In addition to the requirement for IFN-gamma, CD4+ T cells are essential for maintaining a CD8(+)-mediated cure of persistent viral infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7676639     DOI: 10.1006/viro.1995.1477

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  67 in total

1.  Viral persistence in vivo through selection of neutralizing antibody-escape variants.

Authors:  A Ciurea; P Klenerman; L Hunziker; E Horvath; B M Senn; A F Ochsenbein; H Hengartner; R M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

2.  T cell-, interleukin-12-, and gamma interferon-driven viral clearance in measles virus-infected brain tissue.

Authors:  Samantha R Stubblefield Park; Mi Widness; Alan D Levine; Catherine E Patterson
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

3.  Cutting edge: persistently open chromatin at effector gene loci in resting memory CD8+ T cells independent of transcriptional status.

Authors:  Valerie P Zediak; Jonathan B Johnnidis; E John Wherry; Shelley L Berger
Journal:  J Immunol       Date:  2011-01-28       Impact factor: 5.422

4.  IFN-gamma action in the media of the great elastic arteries, a novel immunoprivileged site.

Authors:  A J Dal Canto; P E Swanson; A K O'Guin; S H Speck; H W Virgin
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

Review 5.  CD4 T-cell immunotherapy for chronic viral infections and cancer.

Authors:  Alice O Kamphorst; Rafi Ahmed
Journal:  Immunotherapy       Date:  2013-09       Impact factor: 4.196

6.  The Effects of Dendritic Cell Hypersensitivity on Persistent Viral Infection.

Authors:  Jennifer S Tsau; Xin Huang; Chen-Yen Lai; Stephen M Hedrick
Journal:  J Immunol       Date:  2018-01-08       Impact factor: 5.422

Review 7.  Immunotherapeutic relief from persistent infections and amyloid disorders.

Authors:  Dorian B McGavern
Journal:  Neurology       Date:  2006-01-24       Impact factor: 9.910

8.  A unique variant of lymphocytic choriomeningitis virus that induces pheromone binding protein MUP: Critical role for CTL.

Authors:  Brian C Ware; Brian M Sullivan; Stephanie LaVergne; Brett S Marro; Toru Egashira; Kevin P Campbell; John Elder; Michael B A Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-19       Impact factor: 11.205

9.  Is the TAM receptor Axl a receptor for lymphocytic choriomeningitis virus?

Authors:  Brian M Sullivan; Megan J Welch; Greg Lemke; Michael B A Oldstone
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

10.  Blockade of chronic type I interferon signaling to control persistent LCMV infection.

Authors:  Elizabeth B Wilson; Douglas H Yamada; Heidi Elsaesser; Jonathan Herskovitz; Jane Deng; Genhong Cheng; Bruce J Aronow; Christopher L Karp; David G Brooks
Journal:  Science       Date:  2013-04-12       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.